January 6, 2015 by Brad Perriello
Covidien says shareholders at a meeting in Ireland this morning approved its pending, $43 billion merger with Medtronic.
Covidien (NYSE:COV) said this morning that shareholders voted to approve its pending, $43 billion merger with Medtronic (NYSE:MDT) at a meeting in Ireland.
It’s a penultimate step in consummating the union, announced last summer, as Medtronic shareholders are also slated to meet today for a vote on the deal.
Covidien said its stockholders overwhelmingly approved the merger with Medtronic at the Irish High Court-mandated meeting, and at its own extraordinary general meeting.